Nationwide protests took place as questions remain after border czar Tom Homan announced earlier he ordered federal immigration authorities to work on a drawdown plan for Minnesota.

White House Border czar Tom Homan will address the press in Minneapolis after being sent to take the reins on the Trump administration’s immigration crackdown in Minnesota. Follow for live news ...

(RTTNews) - Enliven Therapeutics, Inc. (ELVN) shares jumped 50.86%, trading at $23.33, up $7.86, after the company reported positive initial Phase 1b data from its ENABLE clinical trial of ELVN-001 in ...

We recently published 10 Market Stars Behind Millionaire-Making in 2025. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the top performers. Terns Pharmaceuticals climbed by 629.64 percent in 2025 ...

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival. When imatinib (Gleevec; Novartis), the first-ever tyrosine kinase inhibitor, made its ...

Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...

The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...

Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for ...